🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Thanks Southern Thoracic Surgical Association (STSA) for the opportunity to share our work Cleveland Clinic Heart, Vascular & Thoracic that suggests cardiac surgery in patients on chronic steroid therapy is safe with favorable outcomes in a nationwide cohort Edward Soltesz MD MPH

What is the efficacy and safety of a transaortic approach to midventricular and apical septal myectomy? Researchers at Cleveland Clinic Heart, Vascular & Thoracic find out in #JTCVS. Read the open access article: doi.org/10.1016/j.jtcv… Aaron J. Weiss, MD PhD David Moros

Longitudinal follow-up in the largest single-centre Heartmate 3 cohort to date characterizing the nuanced temporal patterns in risks of mortality and adverse events. #lvad #hm3 #heartfailure

In our new review, we discuss considerations for patient-specific device tailoring in temporary mechanical circulatory support for cardiogenic shock, along with strategies to facilitate safe mobilization in appropriately selected patients. Aaron J. Weiss, MD PhD link.springer.com/article/10.100…

Trajectories following #Impella 5.5 support are associated with #InitialPresentation #Acuity 👉tinyurl.com/2djja7ju @JLmaigrot Aaron J. Weiss, MD PhD #CardiogenicShock #IntermacsProfile

We are so excited to welcome our incoming class! Jean-Luc Maigrot Andrew Jones Sean H. Kwak Cleveland Clinic Heart, Vascular & Thoracic Cleveland Clinic CTS Residency James Yun Patrick R. Vargo Siva Raja #MatchDay2025

Our program matched great - we’re excited! But today hits different for some. Every main character has a plot twist . Mine still haunts me. DM if it helps - no promises, just advice and shared existential dread #MatchDay2025

Attention medical students attending #AATS2025‼️ Cleveland Clinic CTS Residency and TSMA are hosting a networking event on Friday, May 2nd, at 8 PM. We are excited to meet you and hope that you can join us! AATS

.David Moros presenting on operative mortality of post-myocardial infarction ventricular septal rupture trends, discussing the 54-year single-center study during the #AATS2025 Presidential Plenary.

In pts w/ mitral-induced LVOTO with minimal hypertrophy, MV surgery can eliminate SAM, relieve LVOTO, and resolve MR. Pathoanatomically guided MVr is durable & bioprosthetic MVR is a safe alternative when repair isn’t feasible. Cleveland Clinic CTS Residency Cleveland Clinic Heart, Vascular & Thoracic jtcvs.org/article/S0022-…